CLS Americas at AUA 2023

This year’s conference was fantastic and productive for our company on numerous levels. First of all, our new Backlit Trade Show Booth attracted strong, consistent traffic from interested prospects, partners, and collaborators. Our cool TRANBERG Laser Demo was also a hit showing off our precisely controlled Focal Laser Ablation technology.
Throughout the conference, numerous urologists and potential business partners from the US and EU showed strong interest in our TRANBERG Thermal Therapy system and its minimally invasive approach to treating prostate tissue. We’re currently following up with everyone. Stay tuned for more exciting outcomes!
On behalf of the CLS AUA23 team, thank you to everyone for stopping by. It was my pleasure to meet many of you. I look forward to hopefully hearing from you again in the future should our clinical or business interests align. Best of luck in 2023!
Michael Magnani, President CLS Americas

The CLS team at the AUA2023. Right to Left: Lotta Nilsson,VP Marketing, CLS AB; Rick Wilderotter, Director, Business Development, CLS America’s Inc.; Michael Magnani, President, CLS America’s Inc., and Amani Abou-Zamzam MBA, Urology Strategy Consultant. Joel Hix, Director, Clinical Operations, CLS America’s Inc.  (not pictured).

KOL Dinner Reception with Dr Bianco

CLS also hosted a private KOL dinner reception where Dr. Fernando Bianco was able to share some early results from our first office-based focal laser ablation cases in America. The first twenty patients have been safely treated and follow up is now ongoing. 

Read more about the study here.

Book a meeting with our team

Want to learn more about our 510(k) cleared TRANBERG™ products and latest news? 

Fill out the form below and we´ll contact you. 

CLS Americas

Clinical Laserthermia Systems Americas Inc
Michael Magnani, President

Phone:+1 (949) 504-5440



Public Relations & Media Contact

TopSpin Communications
Joe Waldygo, President

Phone: +1 (480)363-8774 


News and insights

Our latest news are displayed below (links to CLS America webpage).

5 May, 2023

CLS Americas and Unio Health Partners Announce Clinical Study

We are happy to share that CLS Americas has entered into an agreement with Genesis Research, LLC, an affiliate of Unio Health Partners, to conduct a Phase I clinical study titled, “Micro Ultra-Sound Guided, Transperineal Focal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

Read more
13 April, 2023

CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center

Under the agreement, NIHCC will access the clinical utility of the CLS’s TRANBERG® Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male patients.

Read more
21 March, 2023

NEW: Animation showing Fusion-guided Focal Laser Ablation in Prostate Cancer

We are proud to release a detailed video animation of the minimally invasive, fusion-guided, focal laser ablation (FLA) of a prostate tumor using the TRANBERG™ Thermal Therapy System.

Read more

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region